GS43_8. Hold-FAST. strategy
0 likes306 views
1) The proposed strategic plan focuses on improving preparedness for FMD and similar transboundary animal diseases through better training, emergency preparedness tools, and research. 2) It aims to reduce disease risks in Europe and its neighboring regions through coordinated control programs, improved early warning systems, and building veterinary capacity. 3) A third goal is sustaining global progress against FMD through continued support of the Progressive Control Pathway and improving vaccine access and supply.
GS43_8. Hold-FAST. strategy
- 1. HOLD-FAST Staying true to FMD. HOLDING OFF the storm of similar TADS
- 3. ANIMAL HEALTH SECURITY THROUGH BETTER PREPAREDNESS AND REDUCED RISK FROM FMD AND SIMILAR TADS (‘’HOLD-FAST””) The proposed 4 year EuFMD Strategic Plan (April 2019-2023) 2019
- 4. Rationale for the Strategy • FMD remains the #1 disease risk – in the European neighbourhood • Over 250 million cases annually across the world – daily risk of FMD entry into EU : must maintain effort • Capacity, Training and Preparedness tools already developed for FMD are relevant to similar TADS • EuFMD already active in areas where PPR, poxviruses, ASF are present • Adapting spread models (EuFMDis) to similar TADS is straightforward • Europe (+GF-TADS) needs implementing partners able to work effectively at national level in the neighbourhood
- 5. The Strategic Plan in 10 points Non-negotiable values, commitments and behaviours that you can HOLD us to • Continuous co-ordination • Regular review - of the risk situation • Seek synergy - with the relevant EU institutions • Sharing of expertise in emergency preparedness and epidemic management • Continuous engagement with veterinary services • Effective use of European and neighbourhood reference laboratories and expertise • Commitment - to provide world-leading training quality and tools • Continuous improvement- in delivery and impact • An attitude of always seeking to leverage efforts 1. PRINCIPLES
- 6. Focus on FMD: • Every part of the programme to support FMD control • Many parts of the programme relevant to improved control of Similar Transboundary Animal Diseases • Within the Scope Category 1: FMD, and currently PPR, capripoxviruses - Similar risk factors to FMD/in directly bordering neighbourhood/Vaccination is an option Category 2: Rift Valley Fever, Bovine Ephemeral Fever - In one or more neighbourhood countries/vaccination needed/Ruminants are directly affected with major losses Category 3: Not included in the above but kept under review - Currently cause outbreaks in EU-MS (e.g. ASF) / co-ordination is well established at EU level - Other TADS, according to risk 2. SCOPE – FOCUSED but fast to adjust
- 7. 3. OUR THREE GOALS (“Pillars”)
- 8. Goal Objectives Key Performance Indicators (KPI) Improved preparedness 1. National capacity development 2. Regional and national capacity in emergency preparedness 3. Preparedness for use of emergency vaccination 4. South-Eastern Europe 5. Applied research program 6. Proficiency test services (extended EU scheme) 7. FAST disease information gathering and analysis 1. Knowledge Achieved With Training 2. MS satisfaction with CP tools 3. MS satisfaction with EV assessments 4. % countries having tested CP plans for FAST diseases 5. Satisfaction of Technical Committee with completed studies 6. Number of eligible non-EU countries participating 7. MS satisfaction with FAST risk reports Reduced risk 1. Co-ordinated activities (under GF-TADS/REMESA) 2. FAST disease: Improved Early Warning 3. Integrated capacity development 1. PCP-FMD indicators for progress (14 countries) 2. Regular surveys of satisfaction levels with EW system outputs 3. Knowledge Achieved with Training (tested) and numbers trained Sustained global progress 1. Sustained and effective PCP-FMD implementation 2. Improved global laboratory support 3. Better training for progressive control 4. Improved vaccine security 1. Process indicators, completion of Roadmaps and #countries utilising PSO expertise 2. Surveillance targets met in three of the five Roadmaps; system for regional vaccine recommendations being used 3. Knowledge Achieved With Training (tested) and numbers trained 4. PPP: satisfaction of stakeholders in rate of progress Feasible, costed, and achievable 4. OBJECTIVES and KPIs (Fourteen)
- 9. Europe-wide TADS modelling capacity serving MS and the region as a whole (EuFMDis+) Laboratory proficiency and capacity for FAST diseases established across the Balkan countries supported by a diagnostic bank Integrated FAST disease early warning system in the REMESA/neighbourhood region be in place by end of 2020. Vaccine security platform: Addresses a gap affecting contingency planning 5. SIGNIFICANT NEW ELEMENTS to the programme
- 10. World –leading Training Programme GET Prepared Expertise and support to guide MS on stress-testing of their preparedness resources Regionally co-ordinated targeted, national assistance to apply the Progressive Control Pathway (PCP-FMD) Fund for Applied Research (FAR Fund) Studies with generic (multi- TADS) applicability will be favoured Global Intelligence Regular risk reports: but with added FORECASTING 6. CORE ELEMENTS of the programme continued from Phase IV
- 11. Member States govern – through the elected Officers Co-ordination, in a changing disease risk environment • DAILY • Periodic review (@6 month intervals) • With the priorities of GF-TADS Europe Technical support for decisions on changing priorities • Greater role of the Standing Technical Committee (STC) on decisions upon changes in priorities or intensities of efforts on specific TADS 7. GOVERNANCE and CO-ORDINATION with partners
- 12. The programme will be delivered as per Phase IV: Through a dedicated, technically and operationally autonomous Secretariat fully applying the FAO administrative procedures Operational units Senior Management team Executive Secretariat Secretary/Budget Holder Programme Unit: : Lead Technical Officer + Chief Operating Officer (+CFO) Teams for Pillar and Component delivery Horizontal Operational support services Co-ordination and Communications Unit (DOC) Governance Meetings STC and Special Committees Reporting and Communications 8. OPERATIONAL MANAGEMENT
- 13. EuFMD : circa 1m€ p.a Programme Funds (EC request): 3 m€ p.a Component Amount Source identified Programme Budget (Table 2) 3.0 m€ per annum EC: DG-SANTE (request) Programme Management & Secretariat 0.6 m€ per annum Member States annual contributions Scientific Support: FAST-Network and Fund for Applied Research (Special Committee 0.2 m€ per annum Additional voluntary contributions of MS/others Ad –hoc funding of programme elements 0.2 m€ per annum Additional contributions of donors or resource partners Total 4.0 m€ per annum 9. FINANCING: Administrative & Programme Funding
- 14. Programme Funds (EC request): 3 m€ p.a Goal (Pillar) Phase V per annum 1. Improved preparedness 1,559,550 2. Reduced risk 760,450 3. Sustained global progress 680, 000 3,000,000 9. Programme budget estimates 10. Environmental sustainability objectives Programme objectives contribute to reduced global impact (GHG+) of ruminants and operational procedures apply the 3 R’s
- 15. 43rd General Session of the EuFMD • Promoting FMD control which can benefit the global environment by reducing GHG emissions from livestock through globally increased productivity: • Applying the 3Rs in our activities through Reducing: air travel through increasing e-work (webinars, e-learning, skype) and offsetting the carbon footprint from unavoidable travel Re-using: promoting BYOB (Bring Your Own (water) Bottle) Re-cycling: as much as possible in FAO HQ (and at home) Large ruminants are one of the most important sources of GHG and over 60% live in countries which have endemic FMD 10. Thinking of the environmental footprint by
- 16. Strategic Plan 2019-2022 Pillar I Improved preparedness for management of FMD and similar TADS (“FAST diseases”) crises by Members and across Europe as a whole Proposed updating 43rd EuFMD General Session, 17-18 April 2019
- 17. OBJECTIVE 1: NATIONAL CAPACITY DEVELOPMENT EXPECTED OUTPUT Improved level of training in FAST diseases crisis management at national level HOW TO DO IT? Training menu supported by the training credits system • Design of the training menu based on MS needs • What the MS see as their needs • Collaboration with other organizations to identify priorities • Risk based: Collaboration with Pillar II • More country-tailored programs • Incentives to choose the option “assistance with the national training system”
- 18. OBJECTIVE 1: NATIONAL CAPACITY DEVELOPMENT HOW TO DO IT? We have a lot of high quality training material that is useful for all FAST diseases. To develop new training material,… • We will focus on the practical problems countries face • Exit strategy after an outbreak • What reagents would be needed in the first weeks of an outbreak • We will prioritize a regional approach Higher number of open resources (Knowledge Bank /YOUTUBE) • Link to national education organisations • To be used within the FAST national training strategy
- 19. EXPECTED OUTPUT STATE OF THE ART tools for EP available to MS to assess and improve preparedness for FAST diseases across Europe OBJECTIVE 2: REGIONAL CAPACITY IN EMERGENCY PREPAREDNESS (EP)
- 20. HOW TO DO IT? Through the collaborative work with other institutions: EFSA, DG SANTE Dir F, others • GET Prepared: Comprehensive toolbox to assist MS in the assessment and improvement of their contingency plans • EuFMDis+: Pan- European model covering FMD and other FAST diseases, and with new features included such as the wildlife component and biosecurity considerations OBJECTIVE 2: REGIONAL CAPACITY IN PLANNING
- 21. EXPECTED OUTPUTS • Improved CP considering vaccination as an option against FAST diseases • Progress to address barriers to the access to effective vaccines against FAST diseases HOW TO DO IT? 1. Establishment of a Vaccine security platform • Public-private platform (PPP): private sector, RL and R&D experts, vaccine registration and contingency planners to meet on a regular basis • To discuss about and promote progress to the access to effective vaccines against FAST diseases 2. Assured Emergency Supply Options (AESOP) OBJECTIVE 3: PREPAREDNESS FOR USE OF EMERGENCY VACCINATION
- 22. EXPECTED OUTPUTS • Improved emergency preparedness in the region • Improved surveillance systems → Greater confidence in freedom from FAST diseases and increased likelihood of early detection of an incursion OBJECTIVE 4: IMPROVED EP in SOUTH-EASTERN EUROPE (THRACE and BALKANS)
- 23. HOW TO DO IT? OBJECTIVE 4: SOUTH-EASTERN EUROPE THRACE and BALKANS
- 24. HOW TO DO IT? • Thrace +: Possibility to extend the current coordinated regional surveillance approach • Simulation exercises, workshops and continuous support to improve emergency preparedness for FAST diseases • Improve laboratory proficiency and capacity for FAST diseases across the region • Diagnostic bank for FAST diseases (initially: Balkans, but may serve wider need) OBJECTIVE 4: SOUTH-EASTERN EUROPE THRACE and BALKANS
- 25. EXPECTED OUTPUT Tools and new knowledge to improve emergency preparedness against FAST diseases HOW TO DO IT? • Competitive selection of studies to support through the Fund for Applied Research (FAR) • Identification of Europe-wide priorities in emergency preparedness and gaps of tools and knowledge • Expert Committee (SCSAR) - prioritization, guidance on impact of potential studies OBJECTIVE 5: APPLIED RESEARCH PROGRAMME
- 26. RELEVANT TO ALL THE PILLARS HOW TO DO IT? • Continuity of current system (GMR) for information gathering and analysis • Addition of epidemic fore-casting based on intelligence focal points system • Greater integration of informatics and analysis (with OIE/FAO networks) OBJECTIVE 6: PROFICIENCY of the NRLs (non-EU MS) for FMD (extension of the PTS operated under the EU-RL) OBJECTIVE 7: FAST disease intelligence provided for risk assessment
- 27. Goal (Pillar) Component Objectives Subcomponents € Per annum Phase V per annum Per annum Phase IV (2017-18) Phase V Increase % 1. Improved preparedness 1. National capacity development 39 MS @8000 (312,000) 312,000 261,488 19 2. Regional capacity in emergency planning 160,000 71,077 125 3. Preparedness for use of emergency vaccination incl emergency reserves 300,000 161,890 85 4. South-Eastern Europe incl Diagnostic Bank 369,550 289,555 28 FAST Diagnostic Bank 80,000 THRACE surveillance 188,500 Emergency Preparedness and exercises 101,050 5. Applied research program 250,000 186,194 34 6. PTS 30,000 23,150 30 7. Global informatics for Risk assessment 138,000 42,100 228 TOTAL 1,559,550
- 28. Strategic Plan 2019-2022 Pillar II Reduced FMD risk to EUFMD Members from European neighbourhood Proposed updating 43rd EuFMD General Session, 17-18 April 2019
- 29. Priorities and opportunities in the future programme for integration of efforts for risk reduction of FAST diseases Priority: early warning and better preparedness for FMD and Similar TADs in the EU neighbourhood – integrated cost-efficient approach Opportunities: - building on networks established - making use of the horizontal approach - adopting flexible programme - working with partners 43rd EuFMD General Session, 17-18 April 2019
- 30. Risk and threats change - What is needed ? Close coordination and clear roles Flexibility to shift priorities, resources and activities Efficient use of models for early detection (e.g. Thrace) Efficient use of acquired expertise ….and …. • Capacity to work in different setting • Continual presence in the field • Capacity and flexibility to deliver quickly • Combination of experience and innovation
- 31. To achieve FAST progressive control: - Coordinated mechanism under GF-TADs with regular updates of FMD control strategies and definition of priorities and related workplans - Coordination with countries to support national programmes (regional/sub-regional/national activities) COMPONENT 1: COORDINATED ACTIVITIES
- 32. - Collection and analysis of risk information - Definition of hot spot locations - Design risk based multi-disease surveillance - Improve collection and delivery of isolates - Prioritization of vaccines and improve their availability - Facilitate sharing of risk information COMPONENT 2: IMPROVED EARLY WARNING
- 33. - Laboratory capacity - Vet Services capacity (e.g. clinical investigation, surveillance and control) - Effectiveness of control measures (e.g. PVM) - Network among centres of expertise - Application of Terrestrial Animal Health Code COMPONENT 3: CAPACITY BUILDING
- 34. Progressive control (PSO) Early warning Capacity building Trainings Emergency preparedness: Cont. Pl. – AESOP - PRAGMATIST Better use of expertise and budget Horizontal elements of the Pillar II programme Networks (centres of expertise)
- 35. Goal (Pillar) Component Objectives Subcomponents € Per annum Phase V per annum Per annum Phase IV (2017-18) Phase V Increase % 2. Reduced risk 1. Co-ordinated activities (under GF- TADS/REMESA) PCP progress in Turkey/Georgia neighbourhood PCP progress in South and Eastern Mediterranean (REMESA countries) 300,450 297,347 1 150,450 150,000 2. FAST disease: Improved Early Warning Continuous Multi-disease surveillance in three hot-spots FAST surveillance Network 250,000 173,904 44 200,000 50,000 3. Integrated capacity development E-learning Course development Training delivery 210,000 74,000 184 65,000 145,000 Total 760,450
- 36. Strategic Plan 2019-2022 Pillar III Sustained progress of the GF-TADs Global Strategy against FMD and the improved security and supply of effective vaccines 1. Sustained and effective PCP-FMD implementation 2. Improved global laboratory support 3. Better training for progressive control 4. Improved vaccine security 43rd EuFMD General Session, 17-18 April 2019
- 37. 3.1 Sustained Global Progress • Sustained progress of GF-TADs Global Strategy for FMD • Continued support the FMD Working group including improved PCP information management Pillar III – Future workplan
- 38. How to do it? Supporting PCP-FMD application: • PCP-FMD tool-kit • Regional roadmaps • PCP Support Officers (“PSOs”) • Promote risk-based control and management (PCP principles) • Extended program - to support all countries engaging in PCP-FMD • Training system for “”Certification” PSO under GF-TADS – with trained expertise from all roadmap regions • EuFMD to manage system and support development • Leverage additional funds to implement activities Pillar III – Future workplan
- 39. 3.2 Improved Global Laboratory Support HOW TO DO IT? • WRL-FMD and OIE/FAO Laboratory Network • CONTRACTED support - KPI’s are surveillance targets in different regions • Shift in emphasis towards Post-vaccination monitoring and regional vaccine selection and performance • Targeted efforts to improve sampling in address Surveillance gaps • Associated training for all Roadmap regions (online programmes) Pillar III – Future workplan
- 40. 3.3 Better Training for progressive control HOW TO DO IT? • World-leading suite of training courses for national PC programmes: multiple languages and regions • Assist countries (+ partners) to deliver national FMD training (online/mobile access) • Co-ordinated effort with OIE (PPP for progressive control, Safe-Trade,..) and OIE to develop an integrated overall suite of training for FAST diseases Pillar III – Future workplan
- 41. 3.4 Vaccine Security WHY? Lack of Global Vaccine Security affects everyone The confidence that vaccines are affordable, available, effective and accessible to stakeholders HOW TO DO IT? • Platform for stakeholders to review barriers affecting access to vaccines for FAST diseases • bringing together regulators, risk managers, research and private sector stakeholders • Supported by Working groups and associated studies to address information gaps affecting investment decisions Pillar III – Future workplan
- 42. Goal (Pillar) Component Objectives Subcomponents € Per annum Phase V per annum Per annum Phase IV (2017-18) Phase V Increase % 3. Sustained global progress 1. Sustained and effective PCP-FMD implementation PCP support to GF-TADS countries (PSO system) Support PCP Roadmaps Co-ordination/Support tools for PCP implementation 170,000 121,424 40 80,000 50,000 40,000 2. Improved global laboratory support Contract to support OIE/FAO FMD Ref Lab Network Surveillance support 320,000 314,386 2 200,000 120,000 3. Better training for progressive control E-learning Course development Training delivery 140,000 97,766 43 50,000 90,000 4. Improved vaccine security 50,000 - Total 680,000